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Recent findings indicate that in addition to its location in the peripheral plasma membrane, H-Ras is found
in endomembranes like the endoplasmic reticulum and the Golgi complex. In these locations H-Ras is
functional and can efficiently engage downstream effectors, but little is known about how its activation is
regulated in these environments. Here we show that the RasGRF family exchange factors, both endogenous and
ectopically expressed, are present in the endoplasmic reticulum but not in the Golgi complex. With the aid of
H-Ras constructs specifically tethered to the plasma membrane, endoplasmic reticulum, and Golgi complex, we
demonstrate that RasGRF1 and RasGRF2 can activate plasma membrane and reticular, but not Golgi-
associated, H-Ras. We also show that RasGRF DH domain is required for the activation of H-Ras in the
endoplasmic reticulum but not in the plasma membrane. Furthermore, we demonstrate that RasGRF medi-
ation favors the activation of reticular H-Ras by lysophosphatidic acid treatment whereas plasma membrane
H-Ras is made more responsive to stimulation by ionomycin. Overall, our results provide the initial insights
into the regulation of H-Ras activation in the endoplasmic reticulum.
Ras family GTPases, H-Ras, N-Ras, and K-Ras 4B/4A, are
key mediators in signaling pathways that convey extracellular
signals from surface receptors to the interior of the cell, func-
tioning as molecular switches in essential cellular processes
(14, 33). It is well known that in order to be functional, Ras
proteins must be attached to the inner leaflet of the plasma
membrane (PM) (56). This is accomplished by posttransla-
tional lipidic additions that take place in the C terminus, within
a segment that has been termed the heterogeneous or hyper-
variable region (32). This region contains the essential signal
for localizing Ras to membranes: the CAAX box (where C is
cysteine, A is an aliphatic amino acid, and X is serine or
methionine). The CAAX box undergoes a posttranslational
modification that makes it more hydrophobic. The cysteine is
farnesylated, the AAX sequence is proteolysed, and the newly
C-terminal cysteine is carboxymethylated (32). A second signal
is required for efficiently positioning Ras in the membrane.
This is accomplished by palmitoylation of cysteine 181 in N-
Ras and cysteines 181 and 184 in H-Ras. In K-Ras4B, the
second signal consists of a polybasic motif of six lysines (posi-
tions 175 to 180) that is thought to interact electrostatically
with the negatively charged membrane (24–26).
New findings indicate that the three Ras isoforms are lo-
cated in distinct PM microdomains with different biochemical
and physical-chemical characteristics (35, 42). Recently, it was
demonstrated that the information required for accurate mem-
brane localization is contained within the hypervariable region
(29, 55), which also dictates how Ras proteins traffic to their
destinations. Whereas H- and N-Ras traffic to the PM along
the secretory pathway through the Golgi complex, K-Ras4B is
directly routed from the endoplasmic reticulum (ER) to the
PM by still unknown mechanisms (2, 12). Lately, a new twist
has been provided by reports indicating that, in addition to its
location in the PM, H-Ras is present in endomembrane sys-
tems such as endosomes, ER, and the Golgi complex (11, 44).
The presence of H-Ras in these intracellular locations seems
not to be a transient event associated with the transport and/or
recycling of H-Ras proteins to and from the PM; instead, a
pool of H-Ras appears to permanently reside in these or-
ganelles. More importantly, in these endomembranes H-Ras is
active and can signal to downstream effectors like the Raf/
ERKs pathway (11, 12, 44). However, to date, little is known
about the mechanistics and the identity of the proteins in-
volved in the regulation of H-Ras in endomembranes.
RasGRF1 and RasGRF2 are guanine nucleotide exchange
factors (GEFs) that display a high selectivity for H-Ras in vivo
(30, 35). In mammalians, RasGRF1 is expressed at high levels
in the brain, in particular in the hippocampus (34, 54), al-
though traces can also be detected in other tissues (23).
RasGRF2, although expressed at high levels in the central
nervous system, exhibits a more widespread expression pattern
(18). The primary structures of these GEFs reveal a number of
motifs presumably involved in diverse regulatory mechanisms.
These include a Dbl homology (DH) domain, present mainly
in GEFs for the Rho family GTPases. The DH domain is
* Corresponding author. Mailing address: Instituto de Investigacio-
nes Biome´dicas, Consejo Superior de Investigaciones Cientı´ficas, Un-
idad de Biomedicina de la Universidad de Cantabria, Departamento
de Biologı´a Molecular, Facultad de Medicina, C/ Cardenal Herrera
Oria s/n, Santander 39011, Spain. Phone: 34-942-200959. Fax: 34-942-
201945. E-mail: pcrespo@iib.uam.es.
† I.A. and D.M. contributed equally to this study.
1516
 o
n
 M
arch 5, 2014 by Red de Bibliotecas del CSIC
http://m
cb.asm
.org/
D
ow
nloaded from
 
flanked by two pleckstrin homology domains of largely un-
known function, although they are suggested to play a role in
targeting mechanisms (46). Regarding their regulation, it has
been shown that RasGRF1 and RasGRF2 are activated by
G-protein-coupled receptors but are largely insensible to re-
ceptors of the tyrosine kinase type (18, 36, 48, 59). Augmen-
tation of intracellular calcium levels by calcium ionophores can
also bring about the activation of RasGRF1 and RasGRF2.
This is achieved by a mechanism mediated through a calmod-
ulin-binding isoleucine-glutamine (IQ) domain present in the
N terminus of this GEF (7, 18–20; R. E. Cheney and M. S.
Mooseker, Abstract, Mol. Biol. Cell 5:21a, 1994). Further-
more, we have recently demonstrated that the ability of
RasGRF1 to activate Ras is regulated by the Rho family
GTPase Cdc42, by a mechanism that entails the translocation
of RasGRF1 to the cell particulate fraction (3, 4).
Since RasGRF family GEFs can be activated by stimuli
mediated by the G-protein-coupled-type cell surface receptors
and also by stimuli that provoke the release of calcium from
intracellular stores like the ER, these GEFs possess the func-
tional characteristics that turn them into ideal candidates for
regulating the activation of H-Ras in this endomembrane. In
this study we have addressed this hypothesis. Herein, we pro-
vide evidence indicating that RasGRF family GEFs colocalize
with H-Ras in the ER but not in the Golgi complex. We
demonstrate that Ras-GRF1 and RasGRF2 can efficiently in-
duce nucleotide exchange on reticular H-Ras. We present data
about differences in the role played by the RasGRF DH do-
main in the activation of H-Ras at the PM and at the ER.
Finally, we show that RasGRF mediation primes membrane
and reticular H-Ras to activation by distinct stimuli. Overall,
our results provide the initial evidence for the regulation of
H-Ras in the ER.
MATERIALS AND METHODS
Constructs. The plasmid encoding HA-RasGRF1 was provided by R. R.
Mattingly; those encoding FLAG-RasGRF2 wild-type, DH, and IQ were
provided by M. F. Moran; that encoding avian infectious bronchitis virus M1
protein was provided by C. E. Machamer; that encoding KDELr-H-Ras SS was
provided by X. Bustelo; that encoding HA-SOS1 was provided by J. M. Rojas;
that encoding Ras-GRP1 was provided by by J. C. Stone. Plasmids encoding
RasGRF1, RasGRF1 DH and IQ and GFP–H-Ras have been described
previously (3, 22, 35). To generate M1–H-Ras SS, H-Ras SS (C181, 184S) was
prepared by PCR-directed mutagenesis and verified by sequencing. It was then
subcloned in-frame into pCEFL-HA (35). M1 codons 1 to 66 were amplified by
PCR and cloned as a HindIII-BamHI fragment directly upstream of the HA tag.
To generate CD8–H-Ras SS, HA–H-Ras SS was subcloned in pCDNACD8,
directly downstream of the sequence coding for the transmembrane domain of
the CD8 receptor (13). Sequences of the oligonucleotides used for the different
constructs are available on request.
Cell culture. COS-7 and HeLa cells were regularly grown in Dulbecco minimal
essential medium supplemented with 10% fetal calf serum. COS-7 subconfluent
cells were transfected with DEAE-dextran (3) or with LipofectAmine (for cells
used for immunofluorescence studies). HeLa cells were transfected with Lipo-
fectamine. Prior stimulation, cells were starved for 18 h. Lysophosphatide acid
(LPA), brefeldin A, and ionomycin were from Sigma. Epidermal growth factor
was from UBI.
Hippocampal and dorsal root ganglion neurons preparation. Male 3-month-
old Sprague-Dawley rats were housed and sacrificed according to European
Union regulations. Rats were perfused with 3.7% formaldehyde in phosphate-
buffered saline (PBS) (pH 7.4), for 15 min at room temperature. Tissue frag-
ments of the hippocampal formation and dorsal root ganglia were dissected out
of 500-m-thick slices, washed in PBS for 1 h, transferred to a drop of PBS on
a siliconized slide, covered with a coverslip, and squashed by percussion. The
slides with adhered neurons were sequentially dehydrated in 96 and 70% ethanol
at 4°C for 10 min, rinsed in PBS, and processed for immunofluorescence analysis.
Immunofluorescence. Cultured cells were washed twice in PBS, fixed with
3.7% formaldehyde in PBS for 10 min at room temperature, and permeabilized
with 0.5% Triton X-100–PBS for 20 min. Preparations were sequentially incu-
bated with 0.5% Triton X-100–PBS for 15 min, and 0.1 M glycine–PBS for 30 min
and blocked with 1% bovine serum albumin–0.01% Tween 20 in PBS for 5 min.
They were then rinsed in PBS–0.05% Tween 20, incubated for 1 h with the
primary antibodies, washed, and incubated for 45 min with the appropriate
secondary antibodies conjugated to fluorescein isothiocyanate (FITC) or Texas
Red. Coverslips were mounted in VectaShield and sealed with nail polish. Con-
focal microscopy was performed with a Bio-Rad MRC-1024 microscope, using
excitation wavelengths of 488 nm (for FITC) and 543 nm (for Texas Red).
Antibodies. Mouse monoclonal anti-HA was from Babco. Rabbit polyclonal
anti-FLAG was from Invitrogen. Anti-RasGRF2 rabbit and goat polyclonal
antibodies and anti-RasGRF1, anti-ERK2, anti-phospho-ERK, and anti-SOS
rabbit polyclonal antibodies were from Santa Cruz Laboratories. Rabbit pan-
RasGRF was provided by E. Santos (Salamanca, Spain). Rabbit polyclonal
antitransferrin receptor was from Zymed. Mouse monoclonal anti-calnexin was
from Becton Dickinson. Rabbit polyclonal anticalreticulin was from Calbiochem.
Antigiantin mouse monoclonal antibodies were supplied by H. P. Hauri (Basel,
Switzerland). Pan-histone mouse monoclonal antibody was from Boehringer
Mannheim.
Immunoblotting. Total lysates and immunoprecipitates were fractionated in
sodium dodecyl sulfate-polyacrylamide gels and transferred to nitrocellulose
filters as described previously (1). Immunocomplexes were visualized by en-
hanced chemiluminescence detection (Amersham), using horseradish peroxi-
dase-conjugated secondary antibodies (Cappel).
Ras GTP loading. Ras GTP loading was performed basically as described
previously (4). Ras-GTP was affinity sequestered using GST-Raf RBD (amino
acids 1 to 149). Immunoblot analyses were performed as described above, using
anti-HA antibody, and quantitated by densitometry with the program NIH Image
1.60. Ras-GTP levels were related to total Ras protein levels as determined by
anti-HA immunoblotting in the corresponding total-cell lysates.
Kinase assays. ERK2 kinase activities were determined as previously de-
scribed (15), using anti-HA immunoprecipitates with myelin basic protein (MBP)
as the substrate (Sigma).
Subcellular fractionations. Briefly, previously minced and homogenized hip-
pocampi, COS-7 cells, and HeLa cells were incubated in 20 mM HEPES (pH 7.4)
for 20 min in ice and passed five times through 80- to 90- and 23- to 25-gauge
syringes sequentially. Postnuclear supernatants were centrifuged at 100,000  g
for 30 min to yield the S100 (supernatant) and the P100 (pellet) fractions. P100
was resuspended in a volume of 20 mM HEPES (pH 7.4) equal to that of the
S100 fraction. To separate the Triton-soluble and insoluble fractions, 1% Triton
X-100 was added to the P100 fraction, which was then kept for 20 min in ice and
centrifuged at 100,000  g for 30 min. The supernatant (Triton-soluble fraction)
was collected, and the pellet (Triton-insoluble fraction) was resuspended in a
volume of 20 mM HEPES (pH 7.4) equal to that of the Triton-soluble fraction.
Loading buffer was added to samples of the fractions containing equivalent
amounts of protein, and they were fractionated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis.
RESULTS
RasGRFs colocalize with H-Ras in the ER. It is conceivable
that GEFs must be found at some stage in organelles in which
their cognate GTPases are located. Therefore, to study the
involvement of RasGRF family GEFs in the regulation of
H-Ras in endomembranes, we examined whether these GEFs
were detectable in cellular locations, like the ER and the Golgi
complex, where H-Ras seems to be active (11). First, we in-
vestigated the cellular distribution of RasGRF1 and RasGRF2
in their physiological environments. As such, we looked at
hippocampal neurons, where RasGRF1 is naturally expressed
(54). Hippocampal pyramidal neurons, exhibiting their char-
acteristic cellular morphology and dispersed chromatin config-
uration within the nucleus, were immunostained with pan-
RasGRF antibodies, and confocal microscopy revealed that
RasGRF displayed a nonhomogeneous, diffuse cytoplasmic
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pattern, with a few small punctate structures of higher-intensity
staining. These punctate structures were more abundant at the
perinuclear region (Fig. 1A, left panel) and presumably corre-
spond to small tubulovesicular elements of the ER, character-
istic of these small pyramidal neurons of the hippocampal
formation. Staining with anticalnexin, an ER marker, also dis-
closed this typical ER morphology of small vesicles, which were
especially prominent around the nuclear envelope (Fig. 1A,
middle panel). The overlay of RasGRF and calnexin staining
revealed the colocalization of both molecules in the ER, spe-
cially in the punctate structures around the nucleus (Fig. 1A,
right panel). Giantin, a Golgi marker, exhibited the typical
perinuclear localization of the neuronal Golgi complex. How-
ever, the overlay of RasGRF and giantin demonstrated a con-
spicuous absence of RasGRF from the Golgi complex (Fig.
1B). To further substantiate our observations, we also investi-
gated the subcellular distribution of RasGRF2, a GEF whose
expression pattern is not restricted to the nervous system but
can be detected in other tissues and cell lines (18). Immuno-
fluorescence in HeLa cells with RasGRF2 antibodies revealed
that this GEF displayed a reticular pattern, especially marked
in the perinuclear region (Fig. 1C and D, left panels). Endog-
enous RasGRF2 was also evident in regions of the PM (Fig.
1E). Costaining with the ER marker calreticulin demonstrated
a partial although clear colocalization with RasGRF2 in ER
structures (Fig 1C., right panel). On the other hand, upon
costaining with antigiantin, it was found that RasGRF2 was
completely excluded from the Golgi complex (Fig. 1D). To
ascertain that the signals yielded by the RasGRF-specific an-
tibodies were indeed specific, we performed immunofluores-
cence analysis using the pan-RasGRF antibody in dorsal root
ganglia neurons, which do not express RasGRF1 (58). As
shown in Fig. 1F (left panel), no signal was evident in this type
of neuron. Likewise, the anti-RasGRF2 antibody stained neg-
atively in COS-7 cells that lack endogenous RasGRF2 (data
not shown). These results demonstrated that RasGRF1 and
RasGRF2 were present in the ER but not in the Golgi complex
of cells naturally expressing these GEFs.
The cellular localization of endogenous RasGRF1 and
RasGRF2, observed by immunofluorescence, was in agree-
ment with the results obtained when their subcellular distribu-
tion was studied by cellular fractionation. This technique
provided soluble and particulate fractions with minimal cross-
contamination, as verified by immunoblotting using antibodies
against ERK2 and transferrin receptor as markers for the
cytoplasmic and membrane fractions, respectively (Fig. 2, top
panels). RasGRF1 from hippocampal neurons was detected
in the soluble fraction and, more prominently, in the particu-
late fraction, especially in the Triton-insoluble subfraction.
RasGRF2 in HeLa cells exhibited a similar distribution, al-
though it was slightly more prominent in the soluble fraction
(Fig. 2, middle panels). Remarkably, the distribution of Ras-
GRF1 and RasGRF2 in their physiological settings was largely
mirrored in an ectopic expression system like COS-7 cells
transfected with RasGRF1 or with RasGRF2. Even though
these GEF expression levels were notably higher, ectopic Ras-
GRF1 and RasGRF2 segregation was very similar to that ob-
served for the endogenous GEFs (Fig. 2, bottom panels). In
light of this data, we proceeded to determine the cellular lo-
calization of transfected RasGRF GEFs in COS-7 cells in
further detail by immunofluorescence. This should enable us to
validate this model for further experimentation, which other-
wise would be complex in other cellular systems.
In COS-7 cells transfected with HA-tagged RasGRF1,
RasGRF1 was visualized at the PM (Fig. 3A, left and right
panels) and particularly in the perinuclear zone, including the
nuclear envelope and a profuse ER network. Some diffuse
labeling, characteristic of a cytosolic location, was also evident
around the nucleus (Fig. 3A). The ER distribution was con-
firmed by double immunostaining with calreticulin. The over-
lay showed extensive colocalization of the two proteins in the
FIG. 2. Analysis of RasGRF1 and RasGRF2 distribution by cellu-
lar fractionation in hippocampal neurons, HeLa cells, and RasGRF1-
and RasGRF2-transfected (1 g) COS-7 cells, revealed by immuno-
blotting with the indicated antibodies. ERK2 and transferrin receptor
immunoblots served as controls for the soluble and particulate frac-
tions, respectively. Lysates were fractionated as described in Materials
and Methods. Lanes S, S100 soluble fraction; P, P100 particulate
fraction. The particulate fraction was subsequently fractionated into
Triton-soluble (TS) and Triton-insoluble (TI) fractions. WB, Western
blot.
FIG. 1. Subcellular localization of endogenous RasGRFs. (A and B) Localization of RasGRF in hippocampal neurons. Shown are confocal-
micrographs representative of hippocampal pyramidal neurons doubly immunostained with anti-panRasGRF and anticalnexin (red) (A) or giantin
(green) (B). Intense colocalization in punctate structures around the nucleus is indicated by arrow heads. (C to E) Localization of RasGRF2 in
HeLa cells immunostained with anti-RasGRF2 (red) and anti-calreticulin (green) (C) or giantin (green) (D). Localization of RasGRF2 in regions
of the PM is indicated by arrow heads in panel E. Calreticulin costaining demonstrated colocalization with RasGRF2 in the ER, as indicated by
arrowheads in panel C. (F) Confocal micrographs of dorsal root ganglion neurons doubly immunostained with anti-panRasGRF (left panel) and
with anti-pan-histone (right panel). All panels show equatorial sections at the cell nucleus level, except for panel E, which is more tangential. Bars,
10 m (5 m for panels C and F).
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ER. By contrast, costaining with giantin revealed a complete
absence of RasGRF1 from the Golgi complex (Fig. 3B). Sim-
ilar results were obtained for transfected FLAG-RasGRF2.
RasGRF2 was observed in the nuclear envelope, ER, and,
more prominently than RasGRF1, in some domains of the PM
(Fig. 3C and D). Double-staining experiments showed that
RasGRF2 also colocalized with calreticulin in the nuclear en-
velope and in the ER (Fig. 3C) but did not colocalize with
giantin at the Golgi complex (Fig. 3D). For comparative pur-
poses, we also studied the cellular distribution of SOS1. This
GEF exhibited a more diffuse labeling than RasGRF1–2, in-
dicative of a cytoplasmic distribution. SOS1 also localized to
some domains of the PM (Fig. 3E). Double-labeling experi-
ments also demonstrated its localization in the ER and the
nuclear envelope (Fig. 3E) and, similarly to RasGRF1–2, a
complete absence from the Golgi complex (Fig. 3F). Remark-
ably, while all GEFs displayed some degree of cytoplasmic
staining, this was more marked in the cell body and GEFs were
mainly absent from cytoplasmic prolongations like lamellipo-
dia (Fig. 3A, C, E, and F). It is also noteworthy that the
distribution of RasGRF1 and RasGRF2 within the ER was
polarized, being most conspicuous at one of the nuclear poles.
This phenomenon was evident both for ectropically expressed
(Fig. 3A and C) and endogenous (Fig. 1A and C) GEFs.
These results clearly indicated that RasGRF1 and
RasGRF2, expressed at concentrations at which they effec-
tively activate H-Ras at steady state, were present at the ER
and at the PM, locations where H-Ras activation takes place
(11). The next question we addressed was how RasGRF colo-
calized with H-Ras under acute stimulation by agents that
unleash RasGRF exchange activity. For this purpose, their
colocalization in COS-7 cells transfected with GFP-H-Ras in
addition to suboptimal concentrations of RasGRF1 was ana-
lyzed by confocal microscopy. The ability of RasGRF1 at this
concentration to activate H-Ras per se is greatly reduced;
therefore, the basal activity levels of H-Ras are very low. This
condition was indirectly ascertained by immunofluorescence
analysis using antibodies against phosphorylated ERK (data
not shown). Under unstimulated conditions, H-Ras was
present at the PM, Golgi complex, and ER structures including
the nuclear envelope and dispersed cisternae (Fig. 4A, left
panel) whereas RasGRF1 was prominently detected at the ER,
the cytoplasm, and the PM. (Fig. 4A, middle panel). Under
these circumstances, there was little colocalization between
RasGRF1 and H-Ras (Fig. 4A, right panel). This was shown in
further detail by a confocal section extending through the PM,
in which, even though the presence of GFP-H-Ras and Ras-
GRF1 was remarkable (Fig. 4B, left and middle panels), the
overlay was minimal (Fig. 4B, right panel). Upon stimulation
for 5 min with the calcium ionophore ionomycin, a strong
colocalization of the two proteins was observed in some ER
elements, disclosed by an equatorial confocal section (Fig. 4C),
and also in extensive domains of the PM, as demonstrated by
a tangential section disclosing the cell surface (Fig. 4D). A
similar situation was observed in cells treated with LPA, in
which the two proteins colocalized at the perinuclear region,
particularly at the limiting membrane of variable size vesicles
and ER elements (Fig. 4E). A marked colocalization was also
detected at the PM in a confocal section illustrating the cell
surface (Fig. 4F). By contrast, we could not detect colocaliza-
tion of H-Ras and RasGRF1 at the Golgi complex regardless
of the circumstances (data not shown). On the other hand, a
pool of RasGRF1 exhibiting a diffuse staining, typical of cyto-
solic localization, persisted even under LPA stimulation (Fig.
4E and F). Similar results were obtained with RasGRF2 (data
not shown). These data demonstrated that under conditions at
which RasGRF1 is active, this GEF is present and colocalizes
with H-Ras at the PM and ER but not at the Golgi complex.
RasGRF1 and RasGRF2 activate H-Ras in the ER but not in
the Golgi complex. Our results showed a significant colocaliza-
tion of RasGRF1 and RasGRF2 with H-Ras at the PM and the
ER. However, the fact that two proteins share a location does
not necessarily imply a functional relationship. Therefore, it
was important to determine whether RasGRF GEFs could
stimulate nucleotide exchange on H-Ras at the membrane
systems where the two molecules coexisted. For this purpose,
we engineered H-Ras constructs specifically tethered to de-
fined subcellular sites. First, we generated a palmitoylation-
deficient H-Ras by mutating cysteines 181 and 184 to serines
(termed H-Ras SS). This mutant is not efficiently retained in
the PM and exists in a dynamic equilibrium, shifting between
reticular and cytoplasmic pools (11). Next, the signal provided
by the palmitoylation was replaced by an alternative cue that
would specifically direct H-Ras to the desired location. To
deliver H-Ras SS to the ER, we fused to its N terminus amino
acids 1 to 66 of the avian infectious bronchitis virus M protein
(M1), shown to be restricted to reticular endomembranes (49).
A PM-targeted H-Ras SS was generated by placing in its N
terminus the transmembrane domain of the CD8 receptor,
which we have previously shown to be an effective PM anchor
(13). An HA tag was included to enable the detection of the
expressed proteins. In addition, we assayed the activation of
H-Ras at the Golgi complex, using an H-Ras SS N-terminally
fused to the KDEL receptor (KDELr), a resident Golgi pro-
tein at steady state (10, 40). To verify whether our location-
specific H-Ras proteins were correctly distributed, the con-
structs were transfected into COS-7 cells and their localization
was visualized by immunofluorescence using anti-HA antibod-
ies. As shown in Fig. 5A, M1–H-Ras SS displayed a typical
reticular staining and was undetectable at the PM or at the
Golgi. KDELr–H-Ras SS was restricted mainly to the Golgi
apparatus, with very low reticular staining, and virtually absent
FIG. 3. Subcellular localization of ectopic GEFs in COS-7 cells. Shown are confocal laser micrographs of COS-7 cells transfected with
HA-RasGRF1 (A and B), Flag-RasGRF2 (C and D), or HA-SOS1 (E and F) (1 g in each case). Cells expressing these different constructs were
costained with antibodies directed against calreticulin (A, C, and E) or giantin (B, D, and F). RasGRF1 was revealed by anti-HA antibodies in
panel A and by anti-RasGRF1 in panel B. RasGRF2 was revealed by anti-RasGRF2 antibodies in panel C and by anti-FLAG in panel D. SOS1
was revealed by anti-HA antibodies in panel E and by anti-SOS1 in panel F. Arrowheads in panel A indicate RasGRF1 at the PM. Asterisks in
panels A, C, E, and F indicate an absence of GEFs from cytoplasmic extensions such as lamellipodia. Bars, 10 m.
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from the PM (Fig. 5B). CD8–H-Ras SS exhibited a character-
istic peripheral membrane staining, with only traces being de-
tectable at the ER and Golgi (Fig. 5C). Therefore, these results
validated our constructs for further experimentation.
To examine whether RasGRF1 and RasGRF2 were capable
of activating H-Ras in defined membrane systems, we trans-
fected COS-7 cells with the location-specific H-Ras constructs
and with RasGRF1 and RasGRF2. We also included SOS1 for
comparisons. Ras activation was analyzed by pull-down assays
using the GST-Raf Ras-binding domain (RBD) to affinity pre-
cipitate GTP-bound Ras (50), which was revealed by anti-HA
immunoblotting. First, we checked that on cotransfection with
HA-ERK2, as expected, all three GEFs could efficiently acti-
vate ERK2. (Fig. 6A, top panel). In the same fashion, we
ascertained that these GEFs could induce exchange on wild-
type H-Ras to a similar extent (Fig. 6A, upper middle panel).
This was also the case for H-Ras SS. Since this mutant is found
predominantly in the reticulum, this suggested that RasGRF1,
RasGRF2, and SOS1 could stimulate GDP-GTP exchange on
H-Ras ER pool. This was confirmed by probing the activation
of M1–H-Ras SS, revealing that the three GEFs were capable
of inducing a robust exchange on this reticulum-tethered H-
Ras (Fig. 6A, lower middle panel). Likewise, RasGRF1, Ras-
GRF2, and SOS1 also strongly activated CD8–H-Ras SS, in-
dicating that these GEFs could stimulate PM H-Ras (Fig. 6A,
bottom panel). On the other hand, neither RasGRF1,
RasGRF2, nor SOS1 proved competent for catalyzing ex-
change on the Golgi-bound KDELr–H-Ras SS, while under
the same experimental conditions RasGRP1 was capable of
efficiently activating Golgi-targeted H-Ras (Fig. 6B, top), in
agreement with recent reports (6, 10), suggesting that the H-
Ras pool in this organelle was unreactive with or inaccessible
to RasGRF and SOS GEFs. To verify this point further, we
investigated the effects of interfering with Golgi functions on
RasGRF1 signaling. In COS-7 cells cotransfected with
RasGRF1 and HA-ERK2, it was found that neither treatment
with brefeldin A, which causes a redistribution of Golgi pro-
teins to the cytosol and cessation of vesicle formation (28), nor
prolonged culture at 21°C, which blocks post-Golgi transport
(45), had any effect on the activation of ERK2 induced by
RasGRF1 (Fig. 6B, bottom), thereby demonstrating that the
H-Ras Golgi pool is not a necessary mediator for the activation
of the ERK pathway by RasGRF1.
It was of interest to examine, whether endogenous RasGRF
was capable of activating the H-Ras pool present in the ER,
thereby corroborating the physiological relevance of our find-
ings using ectopic RasGRF. To this end, HeLa cells were
transfected with ER-tethered M1–H-Ras SS and subsequently
starved and subjected to stimulation with ionomycin, a well-
known activator of RasGRF GEFs. This treatment resulted in
almost a threefold increase on M1–H-Ras SS GTP levels (Fig.
6C). Since ionomycin could affect Ras GTP levels by different
mechanisms, it was crucial to determine to what extent this
effect of ionomycin on ER H-Ras was attributable to RasGRF.
For this purpose, we used a construct encoding RasGRF1
devoid of its Cdc25 domain (FLAG-GRF1 Cdc25) (3). This
protein acts as a dominant inhibitory mutant by sequestering
upstream activators away from endogenous RasGRF in an
unproductive fashion, since it cannot itself induce nucleotide
exchange. On cotransfecting GRF1 Cdc25 into HeLa cells, it
was found that this construct could diminish ionomycin-in-
duced M1–H-Ras SS GTP levels to almost basal levels. On the
other hand, in spite of being well expressed (data not shown),
GRF1 Cdc25 had no effect on the nucleotide exchange in-
duced by EGF over PM-tethered CD8–H-Ras SS (Fig. 6C), a
process known to be independent of RasGRF, thereby dem-
onstrating the specificity of the inhibitory effects of this con-
struct. These results indicated that endogenous RasGRF was
capable of activating the H-Ras pool present in the ER upon
stimulation with ionomycin.
The RasGRF1 DH domain is required for H-Ras activation
in the ER but not in the PM. Our recent results have demon-
strated that curtailing its DH domain precludes RasGRF1
from activating Ras/ERK (3). Therefore, it was of interest to
determine whether the DH domain was required for activating
H-Ras regardless of its cellular location, or, alternatively, was
necessary only for stimulating a subset of H-Ras in a definite
site. To test this hypothesis, we investigated if a RasGRF1 DH
domain mutant (DH) with a diminished ability for activating
Ras/ERK (3, 22) was competent for activating the reticular and
PM H-Ras pools in COS-7 cells. In agreement with our pre-
vious results, Ras-GTP pull-down assays revealed that the abil-
ity of RasGRF1 DH- to activate total H-Ras experienced a
60% reduction in comparison to the wild-type GEF (Fig.
7A). Interestingly, the DH- mutant activated M1–H-Ras SS
only up to 50% of the level induced by wild-type RasGRF1
(Fig. 7B). However, this mutant was just as efficient as wild-
type RasGRF1 for activating CD8-H-Ras SS (Fig. 7C).
RasGRF2 behaved in an identical fashion: a RasGRF2 DH
domain deletion mutant (DH) (19) was impaired in its ability
to induce exchange on M1–H-Ras SS (Fig. 7D) but was per-
fectly capable of augmenting CD8–H-Ras SS GTP levels (Fig.
7E). These results suggested that the RasGRF DH domain was
required for catalyzing nucleotide exchange in the reticular
fraction but not in the PM H-Ras fraction. We then asked if
these results bore some relationship to the cellular distribution
of RasGRF on curbing the DH domain. To investigate this, we
transfected RasGRF1 DH- into COS-7 cells and examined its
localization. As shown in Fig. 7F, RasGRF1 DH- was markedly
present in the peripheral membrane. However, on the perinu-
clear zone, the reticular pattern characteristic of wild-type Ras-
GRF1 (Fig. 3) was largely lost and the DH- mutant presented
a more diffuse distribution (as shown in the cell on the left)
reminiscent of soluble, cytoplasmic proteins. This result sug-
gested that the diminished ability of DH domain mutant forms
for activating the reticular H-Ras pool was a consequence of
their loss of localization to the ER.
Distinct pools of H-Ras are differently induced by RasGRF-
activating stimuli. Finally, since RasGRF1 and RasGRF2 are
activated by two types of stimuli, mediated by either hetero-
trimeric G proteins or calcium-calmodulin (43), we investi-
gated whether, on mediation by RasGRF, these stimuli pref-
erentially activated H-Ras within a defined location. COS-7
cells were cotransfected with suboptimal concentrations of
RasGRF1 and RasGRF2 in addition to ER- or PM-targeted
H-Ras, and, after starvation, Ras activation was assayed on
stimulation with ionomycin or LPA. As shown in Fig. 8A, in
RasGRF1- and RasGRF2-transfected cells, ionomycin in-
duced only a moderate increase on Ras-GTP levels on the
ER-targeted M1-Ras SS, not even reaching a twofold increase
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FIG. 4. Colocalization of RasGRF1 and H-Ras under stimulation. COS-7 cells were cotransfected with suboptimal concentrations of RasGRF1
(0.1 g) and with GFP–H-Ras (0.25 g) and analyzed using confocal microscopy. (A and B) Basal conditions. An equatorial confocal section at
the level of the cell nucleus (A) and a tangential section illustrating the PM (B) are shown. (C and D) Treatment with 1 M ionomycin for 5 min.
A confocal section at the cell nucleus level (C) and a confocal section sweeping through the cell surface (D) are shown. (E and F) Treatment with
10 M LPA for 5 min. A confocal section at the cell nucleus level (E) and a confocal section illustrating the cell surface (F) are shown. Bars, 10
m (5 m for panel C).
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in either case. As a control, we included mutants defective for
IQ domain functions, IQ for RasGRF2 (19) and IQ for
RasGRF1 (22), that, as expected, were unreactive with iono-
mycin. Notably, the RasGRF-mediated response to ionomycin
was more pronounced on PM-tethered CD8–H-Ras SS (Fig.
8B), suggesting that RasGRF1 and RasGRF2 preferentially
primed the H-Ras PM pool to induction by calcium iono-
phores. Interestingly, the outcome was the opposite for the
effect of LPA. LPA induced almost a threefold increase in
H-Ras activation at the ER mediated by both RasGRF1 and
RasGRF2 (Fig. 8C), but only a small increase in the activation
of the peripheral-membrane H-Ras pool was evident (Fig.
8D). As previously shown for RasGRF1 (27) deletion of the IQ
domain also rendered RasGRF2 unreactive with LPA. These
results demonstrated that depending on its localization, H-Ras
was distinctively sensitive to RasGRF-mediated activation trig-
gered by different types of stimuli.
DISCUSSION
In an attempt to examine the regulation of Ras in endo-
membranes, we have investigated the involvement of RasGRF
family GEFs as regulators of the activation of H-Ras in the ER
and Golgi complex. Identifying the cellular sites to which a
GEF localizes can give important clues to its functions. Previ-
ous studies undertaken with different cell types probing the
distribution of ectopically expressed RasGRF1 by simple frac-
tionation have yielded similar results. RasGRF1 can be found
in the soluble and, more prominently, the particulate fractions
of NIH 3T3 (47), HEK293T (7) and COS-7 (reference 3 and
this study) cells. Using the same method, we show here that
endogenous RasGRF1 from hippocampal neurons fractionates
in a similar fashion. RasGRF1 is also predominantly particu-
late in fractionated rat brain (53). RasGRF2 from HeLa cells
is also markedly detected in the particulate fraction. Separa-
tion of the particulate fraction into Triton-soluble and Triton-
insoluble subfractions revealed that RasGRF1 and RasGRF2
are found in both fractions although mainly in the Triton-
insoluble phase. It is not known to what cellular structure(s)
these fractions correspond. The Triton-soluble fraction prob-
ably represents the bulk membranes, irrespective of their ori-
gin. It is conceivable that the Triton-insoluble fraction may be
partly constituted by PM lipid rafts and caveolae, where H-Ras
is markedly located (42). Indeed, recent results from our lab-
oratory suggest that H-Ras activation by RasGRF1 and
RasGRF2 takes place in these compartments (35). Another
possibility that we cannot presently rule out is that a fraction of
the Triton-insoluble RasGRF1 and RasGRF2 could be asso-
ciated with microtubules. This would not be unprecedented,
since another RasGEF, RasGRP, is partly associated with mi-
crotubules in certain cell types (41). Even though, thus far, no
structures resembling lipid rafts have been described within the
ER, it is becoming clear that this organelle is not a uniform
compartment but, rather, a spatially and functionally hetero-
geneous structure (39). Therefore, it cannot be ruled out that
hitherto unidentified ER-derived structures could also contrib-
ute to the RasGRF1 and RasGRF2 Triton-insoluble pool.
We have extended these biochemical observations with de-
tailed analyses of RasGRF1 and RasGRF2 distribution by
immunofluorescence that reveal that RasGRF1 and RasGRF2
localize strongly to the ER but are completely excluded from the
Golgi complex. This is the case for the endogenous RasGRF
expressed in hippocampal neurons, mainly RasGRF1, since Ras-
GRF2 expression is almost undetectable in hippocampus (21),
and for endogenous RasGRF2 present in HeLa cells. Interest-
ingly, RasGRF distribution in the ER exhibits a polarized pattern,
being most prominent at one of the nuclear poles. The signifi-
cance of this phenomenon is currently unknown. Remarkably, a
localization almost identical to that found in physiological envi-
ronments is observed in COS-7 cells expressing ectopical Ras-
GRF1 or RasGRF2, an observation that suggests that this cellular
system should be used for further experimentation.
Our results demonstrate that on treatment with stimuli that
trigger the enzymatic activity of RasGRF1, there is a marked
augmentation in the colocalization of this GEF with H-Ras at
the PM and at the ER but not at the Golgi complex, in com-
parison to basal, unstimulated conditions under which only
scarce colocalization between RasGRF1 and H-Ras can be
observed at the PM and ER. Seemingly, this increase in colo-
calization between RasGRF1 and H-Ras does not require ma-
jor changes in RasGRF distribution within the cell, since the
gross cellular localization of RasGRF1 and RasGRF2 does not
experience obvious changes under stimulation or as a result of
massive overexpression (our unpublished results). Cellular
fractionation has also failed to identify major changes in
RasGRF1 distribution as a consequence of stimulation (refer-
ence 7 and our unpublished results). This is in sharp contrast to
SOS, which is markedly cytoplasmic under basal conditions but
undergoes an abrupt redistribution to the particulate fraction
as a result of EGF stimulation. This is visualized by a conspic-
uous recruitment to the peripheral membrane and the perinu-
clear region (references 8 and 31 and our unpublished results).
As such, our results suggest that RasGRF activation does not
FIG. 5. Cellular localization of location-specific H-Ras constructs. COS-7 cells were transfected with the indicated constructs (0.25 g in each
case). (A) M1–H-Ras SS. (B) KDELr–H-Ras SS. (C) CD8–H-Ras SS. Immunofluorescence was performed using anti-HA antibodies. Bars, 10 m.
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FIG. 6. Activation of H-Ras by GEFs in distinct membrane systems. (A) (Top) Activation of ERK2 by RasGRFs and SOS1. COS-7 cells were
cotransfected with HA-ERK2 and the indicated GEFs (1 g each). Kinase assays were performed in anti-HA immunoprecipitates, using MBP as
substrate. (Middle) Levels of HA-ERK2 as determined by immunoblotting using anti-HA antibodies. (Bottom) Activation of H-Ras constructs
tethered to defined locations. Ras GTP loading was determined, as described in Materials and Methods, in COS-7 cells transfected with the
different GEFs (1 g) in addition to the site-specific H-Ras constructs (0.25 g), as indicated. H-Ras–GTP levels present in affinity precipitates
using glutathione S-transferase (GST)–Raf RBD as bait and the total H-Ras levels in the corresponding total lysates were detected by anti-HA
immunoblotting. WB, Western blotting; wt, wild type. (B) Activation of H-Ras in the Golgi complex. (Top) Ras GTP loading was determined, as
described in Materials and Methods, with COS-7 cells transfected with the different GEFs (1 g) as indicated, in addition to the Golgi-tethered
KDELr–H-Ras SS construct (0.25 g). (Bottom) Activation of ERK2 by RasGRF1 after treatments that affect the Golgi complex. COS-7 cells were
cotransfected with HA-ERK2 and RasGRF1 (1 g each), treated with 5 g of BFA/ml for 30 min, or subjected to 21°C for 2 h. Kinase assays were
performed with anti-HA immunoprecipitates, using MBP as the substrate. (Lower panel). Protein levels of HA-ERK2 as determined by
immunoblotting using anti-HA antibodies. (C). Activation of reticular H-Ras by endogenous RasGRF. HeLa cells were transfected with M1-H-Ras
SS or with CD8–H-Ras SS constructs (0.25 g) as indicated, in addition to empty vector () or RasGRF1 Cdc25 (0.5 g) (), and stimulated
with 1 M ionomycin or with 100 ng of EGF/ml for 5 min where indicated. Ras-GTP loading was determined as previously described. Data show
the mean of at least three independent experiments relative to the Ras-GTP levels detected in control cells. Error bars indicate standard error of
the mean (SEM).
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FIG. 7. Role of RasGRF1 DH domain on the activation of H-Ras in distinct cellular locations. (A) Activation of total H-Ras by RasGRF1
DH. H-Ras wild-type (wt) (0.25 g) was transfected in COS-7 cells in addition to RasGRF1 wild type and the DH mutant (1 g) as indicated.
(Upper panel) H-Ras–GTP levels from a representative experiment; Ras-GTP loading was determined as described in Materials and Methods.
Data show means and SEM of at least five independent experiments relative to the Ras-GTP levels detected in control cells. (Lower panel)
RasGRF1 expression levels as determined by immunoblotting using anti-RasGRF1 antibodies. (B) Activation of ER-bound M1–H-Ras by
RasGRF1 DH. Data show means and SEM of at least five independent experiments. (C) Activation of PM-tethered CD8–H-Ras by RasGRF1
DH. Data show means and SEM of at least five independent experiments. (D) Activation of ER-tethered M1–H-Ras by RasGRF2 DH.
M1–H-Ras SS (0.25 g) was transfected in COS-7 cells in addition to wild-type RasGRF2 and the DH mutant (1 g) as indicated. (Upper panel)
H-Ras–GTP levels from a representative experiment. Data show means and SEM of at least five independent experiments relative to the Ras-GTP
levels detected in control cells. (Lower panel) RasGRF2 expression levels as determined by immunoblotting using anti-RasGRF2 antibodies.
(E) Activation of membrane-tethered CD8–H-Ras by RasGRF2 DH. Data show means and SEM of at least five independent experiments.
(F) Cellular localization of RasGRF1 DH (1 g) transfected in COS-7 cells. Bar, 10 m.
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FIG. 8. Distinct pools of H-Ras are differentially induced by RasGRF-activating stimuli. (A) Activation of ER-bound H-Ras by ionomycin.
COS-7 cells were cotransfected with M1–H-Ras SS (0.25 g) in addition to vector (hatched bars) or suboptimal concentrations (s  0.1 g) of
constructs encoding RasGRF1 (open bars) or RasGRF2 (solid bars), in their wild-type (wt) versions and IQ domain mutant forms (IQ for
RasGRF1, IQ for RasGRF2). After starvation, the cells were treated with 1 M ionomycin for 5 min where indicated () and Ras-GTP levels
were determined as described above. Data show means and SEM of at least five independent experiments relative to the Ras-GTP levels detected
in control cells. (Lower panel) RasGRF1 and RasGRF2 expression levels as determined by immunoblotting using specific antibodies. (B) Acti-
vation of PM-bound CD8–H-Ras SS by ionomycin. (Upper panel) H-Ras–GTP levels from a representative experiment with RasGRF2. Data show
means and SEM of at least five independent experiments relative to the Ras-GTP levels detected in control cells. (C) Activation of ER-tethered
M1–H-Ras SS by LPA. (Upper panel) H-Ras–GTP levels from a representative experiment with RasGRF2 on activation with 5 M LPA for 5
min where indicated (). Data show means and SEM of at least five independent experiments relative to the Ras-GTP levels detected in control
cells. (D) Activation of PM-bound CD8–H-Ras SS by LPA. Data show means and SEM of at least five independent experiments relative to the
Ras-GTP levels detected in control cells.
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imply massive translocations from one cellular compartment to
another. If any, there would be subtle changes, since they
cannot be identified by immunofluorescence or by fraction-
ation. Overall, the system could be envisioned as a RasGRF
cytoplasmic pool serving as a dormant reserve, readily avail-
able whenever necessary to replenish the RasGRF activatable
pool at confined locations within the targeted organelle. Under
stimulation, RasGRF would experience a short shuttle to H-
Ras compartments within the same organelle, where Ras ac-
tivation would ensure. This model reconciles our observations
showing an increase in the colocalization between RasGRF1
and H-Ras on stimulation with those demonstrating that the
gross subcellular distribution of RasGRF1 is mostly unaltered
under stimulation. In this perspective, spillage of excess
RasGRF to nearby H-Ras compartments could explain the
activation of H-Ras by overexpressed RasGRFs under basal
conditions.
Colocalization at the PM and the ER would just be circum-
stancial evidence in the absence of functional proof that
RasGRF1 and RasGRF2 can activate H-Ras therein. With the
use of H-Ras constructs specifically tethered to the PM, ER,
and Golgi, we have demonstrated that RasGRF1, RasGRF2,
and SOS1 can effectively induce GDP-GTP exchange at the
PM and ER, but not Golgi-associated H-Ras. Furthermore,
treatments that markedly alter Golgi functions do not affect
the output signal of RasGRF1. These functional pieces of
evidence are in full agreement with our data on subcellular
localization, which demonstrate that RasGRF1, RasGRF2,
and SOS1 are present at the PM and ER but not at the Golgi
complex. In this respect, recent data demonstrate that H-Ras
activation at the Golgi is mediated mainly by RasGRP1 (6, 10).
The molecular basis of the attraction toward different endo-
membranes exhibited by distinct Ras GEFs is not known.
Overall, our results demonstrate that RasGRF1, RasGRF2,
and SOS1 mediate in the activation of H-Ras at the ER while
RasGRPs would activate H-Ras at the Golgi complex (6, 10).
These results seem opposed to those in a recent report,
utilizing the “Raichu” construct (37), suggesting that GEFs
activate Ras at the PM but not at the central region of the cell.
As an explanation, this study proposes the interesting hypoth-
esis that Ras GAP activity would exhibit a gradient, with the
highest levels at the central region of the cell, decreasing to-
ward the periphery (38). However, other possibilities are open.
It is possible that Raichu-Ras may not totally reflect the mech-
anism by which endogenous Ras is switched off. Under stimu-
lation, Raichu-Ras will emit a fluorescent signal only when
bound to its own Raf RBD. The likely event of binding to an
endogenous Raf protein would prevent the Raichu system
from emitting an “on” signal. Therefore, Raichu-Ras binding
to any endogenous effector molecule would have a similar
effect to binding to a GAP molecule. Therefore, in addition to
a putative GAP gradient, local increases in Ras effector con-
centrations could contribute to quenching the Raichu-Ras sig-
nal.
Past results from our laboratory have demonstrated that
deleting its DH domain results in a defective RasGRF1, with a
diminished capacity for catalyzing GTP incorporation into Ras
(3). Herein, we have extended this observation by investigating
the role of the DH domain on the activation of H-Ras ER and
PM fractions. We demonstrate that RasGRF1 and RasGRF2
DH mutant forms are impaired in their ability to activate
reticular H-Ras but that their capacity to induce GDP-GTP
exchange on the H-Ras PM fraction is unchanged. Interest-
ingly, the reduced capacity of the RasGRF1 DH mutant for
activating H-Ras in the ER correlates with the loss of its
localization to the perinuclear ER, while its presence at the
PM is unaltered. These results strongly suggest that the DH
domain harbors some targeting signal necessary to adequately
position RasGRF1 in the ER. This signal would be dispensable
for its interaction with the PM. Consistently, we have previ-
ously shown that ablation of the DH domain markedly dimin-
ished the amount of RasGRF1 in the particulate fraction and
that the addition of an H-Ras CAAX box restored the local-
ization of the DH mutant to this subcellular fraction and its
capability to activate Ras (3). Nevertheless, our results indicate
that even the DH mutant retains some activity over the
H-Ras pool in the ER. It is therefore conceivable that other
signals within RasGRF would also contribute to some extent to
the adequate positioning of the GEF and the activation of
H-Ras in this compartment.
Our final goal has been to evaluate whether distinct types of
stimuli that unleash the catalytic activity of RasGRF will stim-
ulate different H-Ras pools. We demonstrate that under
RasGRF mediation, ionomycin preferentially activates H-Ras
at the PM. This was somewhat unexpected, since we reasoned
that because the ER is the main calcium intracellular reservoir,
calcium release would preferentially activate the nearby H-Ras
ER pool. Surprisingly, this was not the case. Calcium-induced
RasGRF activation requires the participation of calmodulin
(20) a protein that is ubiquitous within the cell (51) and has
been shown to intervene in the control of the Ras/ERK path-
way at the PM on calcium efflux (17). Furthermore, calcium-
calmodulin has been recently implicated in the regulation of
K-Ras (52), an isoform that, thus far, has been shown to be
functional only at the PM. Thus, calcium-calmodulin-mediated
mechanisms regulating Ras functions at the PM seem to be
widespread. In contrast to the effect of ionomycin, we have
observed that LPA is most stimulatory over the H-Ras ER
fraction, and this effect was also dependent on the RasGRF2
IQ domain. Other studies indicate that calcium chelators, cal-
modulin inhibitors, or the deletion of the RasGRF1 IQ domain
preclude LPA-mediated activation of the Ras pathway (27, 57),
consistent with our results. It is intriguing how two stimuli that
switch on the same regulatory mechanism will activate H-Ras
differently depending on its location, but our results suggest
that the differences must be in mechanisms other than calmod-
ulin binding.
Compared to the wild-type protein, RasGRF1 and RasGRF2
DH domain mutant forms are impaired over 50% in their
ability to activate total H-Ras (references 3, 19, and 22 and this
study). This would imply that the H-Ras ER fraction is the
main mediator of RasGRF output signal, as opposed to the
H-Ras PM pool. However, we demonstrate that RasGRF can
potently activate PM H-Ras, and the fact that stimuli like
ionomycin lead to a preferential RasGRF-mediated activation
of H-Ras PM pool clearly indicates that RasGRF GEFs are
competent stimulators of PM H-Ras signals under certain cir-
cumstances. The molecular determinants and the cues that
dictate the selectivity of RasGRF toward the ER and PM
H-Ras pools under different stimuli are thus far unknown and
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are under investigation. With our current method, the use of
different H-Ras constructs precludes an accurate quantitative
comparison of H-Ras activation in the PM and the ER. We are
currently designing a system that will enable us to undertake
this task.
Lastly, our study suggests that the presence of H-Ras in the
ER is not simply a temporal event reflecting the transient
passage of this protein toward its final destination at the PM.
In the absence of studies addressing the comparative stabilities
of H-Ras pools at the different cellular locations in relation to
their functions, it is becoming clear that the ER H-Ras pool
possesses remarkable biochemical and biological activities. As
such, non palmitoylated H-RasV12, which accumulates pre-
dominantly in the ER (2, 12), activates Raf, phosphoinositide-
3-kinase, and Jun N-terminal kinase less efficiently that palmi-
toylated H-RasV12 but sufficiently well to retain up to 75% of
its ability to transform NIH 3T3 fibroblasts (9, 11, 25, 26). In
agreement with these data, we demonstrate here that within
this location, H-Ras is fully responsive to GEFs. This may
seem in conflict with a recent study in which no activation of
Ras was detected on the ER, as opposed to the Golgi, upon
mitogenic stimulation (11). However, it should be noticed that
that study was undertaken with COS-1 cells, which do not
express RasGRF1 or RasGRF2 (our unpublished results).
Furthermore, the mitogenic stimulus used therein was epider-
mal growth factor, to which any trace of RasGRF would be
entirely unresponsive (18, 36, 48, 59). Therefore, rather than
contradicting our present results, it adds further support to the
notion that RasGRF family GEFs would be the main media-
tors of Ras activation in the ER and suggests that SOS, which
we demonstrate herein to be capable of activating the H-Ras
ER pool, would play a more restricted role in the activation of
Ras at this location.
From our data, it can be concluded that the PM H-Ras pool
is a nonspecific target for all RasGEF families, since RasGRFs,
SOSs, and RasGRPs (10) are all capable of catalyzing nucle-
otide exchange therein. H-Ras activation in endomembranes
appears to be a more selective process, where different
RasGEF families display marked preferences. The explanation
of this phenomenon is not known but may indicate some re-
lationship with the tissue-specific roles that Ras-GRPs and
RasGRFs possess (43). In this respect, it is well known that
RasGRFs are preferentially expressed in the nervous system
(18, 21, 34, 54), in particular in mature neurons (58), basically
non-proliferative tissue. Therefore, it could be hypothesized
that the role of RasGRF could be that of a GEF specialized in
regulating Ras signaling under nonmitogenic stimulation. Al-
though highly speculative at this stage, evidence is mounting
that spatial and temporal variations in calcium signals can
dramatically affect biological outcomes (16). For example, cal-
cium triggers exocytosis within microseconds at the synaptic
junctions but calcium signals that last over minutes to hours
are required to drive events such as gene transcription or cell
proliferation (5). Therefore, it is tempting to speculate that at
the ER, the main source of internal calcium, the function of
RasGRF would be that of a GEF especially sensitive to acute,
short-duration calcium peaks, thereby modulating the activa-
tion of Ras in a nonproliferative fashion. As of today, the
biological significance of the activation of H-Ras in endomem-
branes is still unclear. Among the plethora of H-Ras biochem-
ical and biological functions, we ignore those that are being
specifically regulated from the different, confined platforms
where Ras activation ensues. Without any doubt, this will be a
hot topic of research in the near future and will surely provide
valuable clues to explain the specific roles of GEFs in distinct
endomembrane systems.
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